Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-810-4 | CAS number: 68915-38-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Remarks:
- (BASF AG, Department of Experimental Toxicology and Ecology)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Cyclohexane, oxidized, aquous extract
- IUPAC Name:
- Cyclohexane, oxidized, aquous extract
- Reference substance name:
- Cyclohexane, oxidized, aq. ext.
- EC Number:
- 272-810-4
- EC Name:
- Cyclohexane, oxidized, aq. ext.
- Cas Number:
- 68915-38-8
- Molecular formula:
- not available
- IUPAC Name:
- Cyclohexane, oxidized, aq. ext.
- Details on test material:
- - Name of test material (as cited in study report): EP306/Acid Water
- Physical state: liquid, brownish
- Composition of test material, percentage of components:
The following results were obtained for the test item:
Formic acid 1.8 g/100g
Succinic acid 0.37 g/100g
Glutaric acid 1.3 g/100g
Adipic acid 14.3 g/100g
Acetic acid 0.30 g/100g
Propionic acid 0.23 g/100g
Butyric acid 0.65 g/100g
Valeric acid 0.76 g/100g
Hexane acid <0.1 g/100g
6-Hydroxy caproic acid 7.6 g/100g
The following results were obtained for the saponificated test item:
Formic acid 1.8 g/100g
Succinic acid 0.50 g/100g
Glutaric acid 1.7 g/100g (increase)
Adipic acid 18.1 g/100g (strong increase)
Acetic acid 0.50 g/100g (increase)
Propionic acid 0.17 g/100g
Butyric acid 0.09 g/100g
Valeric acid 0.76 g/100g
Hexane acid <0.1 g/100g
6-Hydroxy caproic acid 14.1 g/100g (strong increase)
- Stability under test conditions: storage stability are guaranteed throughout the study period
- Storage condition of test material: room temperature
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Germany GmbH
- Age at study initiation: 5-8 weeks
- Mean weight at study initiation: 29.3 g
- Housing: single
- Diet (e.g. ad libitum): standardized pelleted feed, Kaiseraugst
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: due to the good emulsifying of the test substance in corn oil - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The substance to be administered per kg body weight was emulsified in corn oil. To achieve an emulsion of the test substance in the vehicle, the test substance preparation was shaken thoroughly. All test substance formulations were prepared immediately before administration.
- Duration of treatment / exposure:
- 2 applications with a 24 h interval inbetween.
- Frequency of treatment:
- 2
- Post exposure period:
- 24 h after last application
Doses / concentrations
- Remarks:
- Doses / Concentrations:
500, 1000 and 2000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - Cyclophosphamide (CPP), 20 mg/kg bw once orally in a volume of 10 ml/kg bw
- Vincristine sulfate (VCR), 0.15 mg/kg bw, ip
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: In a pretest for the determination of the acute oral toxicity, following twice administration with a 24-hour interval 2000 mg/kg bw, the recommended highest dose according to the OECD Guideline was tolerated by all animals (male and female) without any signs or symptoms. Thus, only male animals were used for the cytogenetic investigations. Therefore, a dose of 2000 mg/kg bw was selected as the highest dose in the present cytogenetic study. 1000 mg/kg and 500 mg/kg bw were administered as further doses.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): The animals of the vehicle control group and the dose groups were treated twice orally (gavage) with a volume of 10 ml/kg body weight of the test substance with a 24-hour interval between both administrations. Animals of the positive control groups were treated only once. All animals were sacrificed 24 hours after the last treatment, respectively.
- Evaluation criteria:
- Acceptance criteria
The mouse micronucleus test is considered valid if the following criteria are met:
- The quality of the slides must allow the evaluation of a sufficient number of analyzable cells; i.e. = 2000 PCEs per animal and a clear differentiation between PCEs and NCEs.
- The ratio of PCEs/NCEs in the concurrent vehicle control animals has to be within the normal range for the animal strain selected.
- The number of cells containing micronuclei in vehicle control animals has to be within the range of the historical negative control data both for PCEs and for NCEs.
- The two positive control substances have to induce a distinct increase in the number of PCEs containing small and/or large micronuclei within the range of the historical positive control data or above.
Assessment criteria
A finding is considered positive if the following criteria are met:
- Statistically significant and dose-related increase in the number of PCEs containing micronuclei.
- The number of PCEs containing micronuclei has to exceed both the concurrent vehicle control value and the range of the historical negative control data.
A test substance is considered negative if the following criteria are met:
- The number of cells containing micronuclei in the dose groups is not statistically significant increased above the concurrent vehicle control value and is within the range of the historical negative control data.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Clinical signs of toxicity in test animals: The limit dose of 2000 mg/kg body weight was tolerated by all animals (male and female) without any signs or symptoms.
RESULTS OF DEFINITIVE STUDY
-The two oral administrations of the vehicle corn oil in a volume of 10 m/kg body weight led to the ratio of 1.1 (polychromatic erythrocytes containing micronuclei).
-After two administrations of the highest dose of 2000 mg/kg bw, the ratio of 0.8 (polychromatic erythrocytes containing micronuclei) was found.
- In the two lower dose groups, ratio (polychromatic erythrocytes containing micronuclei) of 1.4 each (500 and 1 000 mg/kg bw group) were detected.
- In all dose groups the number of normochromatic or polychromatic erythrocytes containing small micronuclei (d < D/4) or large micronuclei (d > D/4) was close to the concurrent vehicle control value and was within the historical negative control data range.
- The positive control substance for clastogenicity, cyclophosphamide, led to a statistically significant increase (a ratio of 13.4) in the number of polychromatic erythrocytes containing exclusively small micronuclei, as expected. Vincristine sulfate, a spindle poison agent, produced a clear statistically significant increase (a ratio of 38.4) in the number of polychromatic erythrocytes containing micronuclei with the expected amount of large micronuclei, i.e. a ratio of 7.6.
-The number of normochromatic erythrocytes containing micronuclei did not distinctly differ to any appreciable extent in the vehicle control group or in the various dose groups.
- No inhibition of erythropoiesis induced by the treatment of mice with EP306/Acid Water was detected, the ratio of polychromatic to normochromatic erythrocytes was always in the same range as that of the vehicle control values in all dose groups.
Any other information on results incl. tables
Dose groups |
Total numbers of |
MN in |
||
PCE |
NCE |
PCE |
NCE |
|
Vehicle |
10000 |
3408 |
1.1 |
0.3 |
500 mg/kg bw |
10000 |
3822 |
1.4 |
0.8 |
1000 mg/kg bw |
10000 |
3889 |
1.4 |
0.0 |
2000 mg/kg bw |
10000 |
3995 |
0.8 |
0.5 |
CPP 20 mg/kg bw |
10000 |
4024 |
13.4* |
0.0 |
VCR 0.15 mg/kg bw |
10000 |
6004 |
38.4* |
0.3 |
PCE = polychromatic erythrocytes
NCE = normochromatic erythrocytes
MN = Micronuclei
* p =0.01
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.